Research ArticleClinical Investigations
Addition of 18F-FDG PET/CT to Clinical Assessment Predicts Overall Survival in HNSCC: A Retrospective Analysis with Follow-up for 12 Years
Vasavi Paidpally, Abdel K. Tahari, Stella Lam, Krishna Alluri, Shanthi Marur, Wayne Koch, Richard L. Wahl and Rathan M. Subramaniam
Journal of Nuclear Medicine December 2013, 54 (12) 2039-2045; DOI: https://doi.org/10.2967/jnumed.113.121285
Vasavi Paidpally
1Russell H. Morgan Department of Radiology and Radiological Sciences, Johns Hopkins University, Baltimore, Maryland
Abdel K. Tahari
1Russell H. Morgan Department of Radiology and Radiological Sciences, Johns Hopkins University, Baltimore, Maryland
Stella Lam
1Russell H. Morgan Department of Radiology and Radiological Sciences, Johns Hopkins University, Baltimore, Maryland
Krishna Alluri
1Russell H. Morgan Department of Radiology and Radiological Sciences, Johns Hopkins University, Baltimore, Maryland
Shanthi Marur
2Department of Medical Oncology, Johns Hopkins University, Baltimore, Maryland; and
Wayne Koch
2Department of Medical Oncology, Johns Hopkins University, Baltimore, Maryland; and
3Department of Otolaryngology and Head and Neck Surgery, Johns Hopkins University, Baltimore, Maryland
Richard L. Wahl
1Russell H. Morgan Department of Radiology and Radiological Sciences, Johns Hopkins University, Baltimore, Maryland
2Department of Medical Oncology, Johns Hopkins University, Baltimore, Maryland; and
Rathan M. Subramaniam
1Russell H. Morgan Department of Radiology and Radiological Sciences, Johns Hopkins University, Baltimore, Maryland
2Department of Medical Oncology, Johns Hopkins University, Baltimore, Maryland; and
In this issue
Journal of Nuclear Medicine
Vol. 54, Issue 12
December 1, 2013
Addition of 18F-FDG PET/CT to Clinical Assessment Predicts Overall Survival in HNSCC: A Retrospective Analysis with Follow-up for 12 Years
Vasavi Paidpally, Abdel K. Tahari, Stella Lam, Krishna Alluri, Shanthi Marur, Wayne Koch, Richard L. Wahl, Rathan M. Subramaniam
Journal of Nuclear Medicine Dec 2013, 54 (12) 2039-2045; DOI: 10.2967/jnumed.113.121285
Addition of 18F-FDG PET/CT to Clinical Assessment Predicts Overall Survival in HNSCC: A Retrospective Analysis with Follow-up for 12 Years
Vasavi Paidpally, Abdel K. Tahari, Stella Lam, Krishna Alluri, Shanthi Marur, Wayne Koch, Richard L. Wahl, Rathan M. Subramaniam
Journal of Nuclear Medicine Dec 2013, 54 (12) 2039-2045; DOI: 10.2967/jnumed.113.121285
Jump to section
Related Articles
Cited By...
- PET/CT Versus Standard Imaging for Prediction of Survival in Patients with Recurrent Head and Neck Squamous Cell Carcinoma
- A PET/CT-Based Strategy Is a Stronger Predictor of Survival Than a Standard Imaging Strategy in Patients with Head and Neck Squamous Cell Carcinoma
- 18F-FDG PET/CT: Therapy Response Assessment Interpretation (Hopkins Criteria) and Survival Outcomes in Lung Cancer Patients
- 111In-Cetuximab-F(ab')2 SPECT and 18F-FDG PET for Prediction and Response Monitoring of Combined-Modality Treatment of Human Head and Neck Carcinomas in a Mouse Model
- 18F-FDG PET/CT and Lung Cancer: Value of Fourth and Subsequent Posttherapy Follow-up Scans for Patient Management
- Head and Neck PET/CT: Therapy Response Interpretation Criteria (Hopkins Criteria)--Interreader Reliability, Accuracy, and Survival Outcomes
- Follow-up or Surveillance 18F-FDG PET/CT and Survival Outcome in Lung Cancer Patients
- PET/CT Imaging and Human Papilloma Virus-Positive Oropharyngeal Squamous Cell Cancer: Evolving Clinical Imaging Paradigm